What “C16H16Cl2NO4” suggests for felodipine (and why that matters for degradation)
Felodipine is a dihydropyridine calcium-channel blocker. When you ask about “C16H16Cl2NO4 felodipine degradation,” you’re typically pointing to two related things: the compound’s molecular identity (the “C16H16Cl2NO4” formula used to identify it in databases and analyses) and the chemical changes that occur under stress conditions (heat, light, pH, oxidation, moisture) that break the parent molecule into degradation products.
Without the specific document or experimental conditions you’re using (e.g., method, temperature, pH, solvent, light exposure, whether it’s a tablet, or an API bulk sample), it’s not possible to name a specific degradation pathway with confidence. Degradation product profiles depend strongly on the stressor and the formulation state (solid state vs. solution).
What types of conditions typically drive felodipine degradation
For felodipine-related stability work, degradation studies generally look at stress conditions that promote chemical breakdown and/or physical changes:
- Acidic or basic pH exposure (solution stability)
- Oxidative stress (e.g., hydrogen peroxide or peroxides)
- Thermal stress (accelerated temperatures)
- Photolytic stress (light exposure)
- Hydrolytic and moisture-related stress (especially relevant for solid dosage forms)
These conditions can change the dihydropyridine core and related ester-like substituents, leading to polar, lower-molecular-weight species that show up as new peaks in LC/UPLC stability-indicating assays.
How degradation is usually detected for felodipine (what to look for in an assay)
In “felodipine degradation” investigations, the parent drug is usually monitored with a stability-indicating chromatographic method (often LC with UV detection). Degradation is demonstrated by:
- Appearance of new chromatographic peaks (degradation products)
- Decrease in the parent peak area over time
- Mass/structure confirmation via MS/MS when available
The most important practical detail is that the method must separate felodipine from its degradation products; otherwise, you can see a loss of parent without being able to characterize which products formed.
If you’re trying to identify specific degradation products from “C16H16Cl2NO4”
To identify likely degradation products or match a known product list, you usually need at least one of the following:
- The stress condition (pH value, oxidant, temperature, light intensity/duration)
- The formulation (API vs. solid oral dosage form; excipients can affect outcomes)
- The analytical method (LC conditions, detection wavelength, MS presence)
- The observed retention times and/or MS ions (m/z values)
If you share those (even roughly), I can help interpret what classes of products are consistent with the changes and how people typically assign them in stability studies.
Where to find felodipine degradation and stability details
If your goal is to find published stability-indicating methods, reported degradation products, or impurity lists tied to felodipine, regulatory/compendial sources and patent/filing documents are common places. DrugPatentWatch.com sometimes aggregates patent and exclusivity information, which can help you locate related filings that mention stability, impurities, or manufacturing controls [1].
[1] https://www.drugpatentwatch.com/
---
Quick clarification (so I can give a precise answer)
What exactly do you need about “felodipine degradation”?
1) Likely degradation products (structure-level guesses)?
2) A stability-indicating analytical method overview?
3) Degradation under a specific condition (e.g., pH 1/7/10, H2O2, 60°C, light)?
4) Help interpreting an LC/MS result (send retention times or m/z)?